ENST00000482565.1:n.141C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The ENST00000482565.1(HBA2):​n.141C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0047 ( 0 hom., cov: 4)
Exomes 𝑓: 0.0081 ( 64 hom. )
Failed GnomAD Quality Control

Consequence

HBA2
ENST00000482565.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.782

Publications

0 publications found
Variant links:
Genes affected
HBA2 (HGNC:4824): (hemoglobin subunit alpha 2) The human alpha globin gene cluster located on chromosome 16 spans about 30 kb and includes seven loci: 5'- zeta - pseudozeta - mu - pseudoalpha-1 - alpha-2 - alpha-1 - theta - 3'. The alpha-2 (HBA2) and alpha-1 (HBA1) coding sequences are identical. These genes differ slightly over the 5' untranslated regions and the introns, but they differ significantly over the 3' untranslated regions. Two alpha chains plus two beta chains constitute HbA, which in normal adult life comprises about 97% of the total hemoglobin; alpha chains combine with delta chains to constitute HbA-2, which with HbF (fetal hemoglobin) makes up the remaining 3% of adult hemoglobin. Alpha thalassemias result from deletions of each of the alpha genes as well as deletions of both HBA2 and HBA1; some nondeletion alpha thalassemias have also been reported. [provided by RefSeq, Jul 2008]
HBA2 Gene-Disease associations (from GenCC):
  • alpha thalassemia spectrum
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
  • erythrocytosis, familial, 7
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • hemoglobin M disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Hb Bart's hydrops fetalis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • hemoglobin H disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Heinz body anemia
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • methemoglobinemia, alpha type
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 16-173034-C-T is Benign according to our data. Variant chr16-173034-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 439773.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAdExome4 allele frequency = 0.00812 (3751/461772) while in subpopulation NFE AF = 0.0105 (2867/273496). AF 95% confidence interval is 0.0102. There are 64 homozygotes in GnomAdExome4. There are 1857 alleles in the male GnomAdExome4 subpopulation. Median coverage is 2. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 64 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HBA2NM_000517.6 linkc.95+27C>T intron_variant Intron 1 of 2 ENST00000251595.11 NP_000508.1 P69905D1MGQ2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HBA2ENST00000251595.11 linkc.95+27C>T intron_variant Intron 1 of 2 1 NM_000517.6 ENSP00000251595.6 P69905

Frequencies

GnomAD3 genomes
AF:
0.00474
AC:
86
AN:
18128
Hom.:
0
Cov.:
4
show subpopulations
Gnomad AFR
AF:
0.00115
Gnomad AMI
AF:
0.0139
Gnomad AMR
AF:
0.00524
Gnomad ASJ
AF:
0.00398
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00213
Gnomad FIN
AF:
0.00200
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00705
Gnomad OTH
AF:
0.00327
GnomAD2 exomes
AF:
0.00696
AC:
427
AN:
61338
AF XY:
0.00673
show subpopulations
Gnomad AFR exome
AF:
0.00138
Gnomad AMR exome
AF:
0.00774
Gnomad ASJ exome
AF:
0.00469
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00238
Gnomad NFE exome
AF:
0.0123
Gnomad OTH exome
AF:
0.0118
GnomAD4 exome
AF:
0.00812
AC:
3751
AN:
461772
Hom.:
64
Cov.:
2
AF XY:
0.00761
AC XY:
1857
AN XY:
243904
show subpopulations
African (AFR)
AF:
0.00227
AC:
27
AN:
11878
American (AMR)
AF:
0.00678
AC:
168
AN:
24782
Ashkenazi Jewish (ASJ)
AF:
0.00845
AC:
125
AN:
14790
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30956
South Asian (SAS)
AF:
0.00207
AC:
100
AN:
48322
European-Finnish (FIN)
AF:
0.00652
AC:
192
AN:
29438
Middle Eastern (MID)
AF:
0.00357
AC:
7
AN:
1960
European-Non Finnish (NFE)
AF:
0.0105
AC:
2867
AN:
273496
Other (OTH)
AF:
0.0101
AC:
265
AN:
26150
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
218
436
655
873
1091
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00470
AC:
85
AN:
18098
Hom.:
0
Cov.:
4
AF XY:
0.00535
AC XY:
43
AN XY:
8040
show subpopulations
African (AFR)
AF:
0.00115
AC:
3
AN:
2616
American (AMR)
AF:
0.00522
AC:
12
AN:
2298
Ashkenazi Jewish (ASJ)
AF:
0.00398
AC:
2
AN:
502
East Asian (EAS)
AF:
0.00
AC:
0
AN:
1324
South Asian (SAS)
AF:
0.00216
AC:
2
AN:
926
European-Finnish (FIN)
AF:
0.00200
AC:
2
AN:
1000
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
124
European-Non Finnish (NFE)
AF:
0.00695
AC:
62
AN:
8922
Other (OTH)
AF:
0.00318
AC:
1
AN:
314
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00583
Hom.:
3

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 31, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 21, 2022
Quest Diagnostics Nichols Institute San Juan Capistrano
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
6.9
DANN
Benign
0.84
PhyloP100
0.78
PromoterAI
-0.077
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs558457816; hg19: chr16-223033; API